SIEMENS Healthineers is a global provider of healthcare solutions and services in diagnostic, therapeutic imaging, laboratory and point-of-care diagnostics as well as clinical consulting services, in >180 countries. Siemens has 170 years of experience, 18K patents, and is a leader in imaging and endovascular robotics, with cardiac radioablation being designated a “breakthrough device” by the FDA for patients with refractory ventricular tachycardia. With 67 AI-based products and applications on the market, Siemens was awarded the EU Privacy Seal for data protection. As a market leader, SHS aims to advance a world in which breakthroughs in healthcare create new possibilities with minimal impact on the planet. They have been pushing the boundaries in medical technology for more than 125 years. By consistently bringing innovations to the market, SHS enables healthcare professionals to innovate personalised care, achieve operational excellence, and transform the system of care. SHS owns a supercomputer HPC, a high-performance computing platform that uses artificial intelligence and machine learning to accelerate medical research and improve patient care. Digital Twinning, together with digital data and AI and precision therapy are the three main pillars of research of Siemens Healthineers to go towards pioneering breakthroughs in healthcare, for everyone, everywhere.